We are live on ! Find out more
CRMD icon

CorMedix

34 hedge funds and large institutions have $4.26M invested in CorMedix in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 5

3% more funds holding

Funds holding: 33 → 34 (+1)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

1.51% less ownership

Funds ownership: 14.17% → 12.66% (-1.5%)

16% less capital inflows, than outflows

Capital inflows: $536K | Capital outflows: $636K

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $56K

Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
8
Reduced
5
Closed
4
Calls
–
Puts
$56​K
Net Calls
-⁠$56​K
Net Calls Change
+$11​K

CRMD Hedge Fund Activity: Q4 2017 in Review

34 of the 4,418 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2017, worth a combined $4.26M — down 2.7% from $4.38M a quarter earlier.

Fund positioning in CRMD was balanced in Q4 2017: 4 funds opened new positions, 4 closed out, 8 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $291K. The largest seller was Sabby Management, exiting entirely with an estimated $337K sold.

  • 34 institutional investors held CorMedix (CRMD) as of Q4 2017, up from 33 in Q3 2017.
  • Funds reported $4.26M of CorMedix stock for Q4 2017, down 2.7% quarter-over-quarter.
  • 4 funds opened new CorMedix positions in Q4 2017 and 4 closed out, a net change of 0 holders.
  • The largest CorMedix buyer in Q4 2017 was Vanguard Group, an estimated $291K added.
  • The largest CorMedix seller in Q4 2017 was Sabby Management, an estimated $337K sold.

Based on aggregated 13F filings for Q4 2017.